Join us for the Pickle for Pink Tournament & Fundraiser to raise money for breast cancer research, education, and patient care programs at Duke.
📆 Friday, Oct. 30-Sunday, Nov. 1
⏰ 8 a.m.-4 p.m.
📍 The Duke Faculty Club
duke.is/pickleforpink
ALT Pickle for Pink participants at last year's event
Join the @dukemets for its annual research retreat, featuring sessions and panel discussions on ongoing research and innovations at Duke.
📆 Thursday, Oct. 1
⏰ 8 a.m.-2 p.m.
📍 Trent Semans Center for Health Education - Great Hall
duke.is/j/jaen@DukeMedSchool
"We are riding in honor of our parents/grandparents who both fought and lost their battles with cancer. We want to help others have hope for a cure." – Darlene Kepnes, Duke Health Employee
Join us Oct 3 in Durham, NC. Register at DukeRides.org.
ALT This image features a promotional poster for "Duke Rides" benefiting the Duke Cancer Institute. It includes a headshot of a person wearing glasses. Next to the person is the Duke Blue Devils mascot with "#DukeRides" written on a headband. The text reads "Why I'm Riding" followed by "Darlene Kepnes.
A promising new immunotherapy is changing the treatment landscape for advanced small cell lung cancer. Duke Health offers specialized expertise in tarlatamab, helping patients access innovative care and new opportunities for treatment. Learn more.
duke.is/BiTEtherapy
ICYMI: A new study led by DCI researchers offers important insights into that challenge in advanced prostate cancer and could help pave the way for more personalized treatment approaches in the future.
duke.is/c/tbvz#ProstateCancer | @DukeMedSchool | @DukeHealth
"I ride for the patients, caregivers, and medical teams impacted by cancer. My sister Carol lost her 7-year battle — Carol's Crew rides in her honor." – Sue Harnett, Duke '90
Join us Oct 3 in Durham, NC. Register at DukeRides.org.
ALT Person smiling while seated indoors, with a Duke Rides promotional background featuring a logo and the Duke Blue Devil mascot. Text reads 'Why I'm Riding Sue Harnett.'
Connect, & ask questions at this year’s What’s Best for Breast event. This event includes presentations & interactive sessions on breast imaging, genetic testing, cancer risk, and more.
📆 Saturday, Oct. 3
⏰ 8 a.m.-3 p.m.
📍 Duke Trent Semans Great Hall
Learn more & register:
"I ride for the patients and families fighting pancreatic cancer today—and for those who will need us tomorrow." – Dr. Daniel Nussbaum
Join us Oct 3 in Durham, NC. Register at DukeRides.org.
ALT Image promoting 'Duke Rides' benefiting Duke Cancer Institute. Features a person in a white coat with 'Duke Surgery' logo, smiling, alongside a graphic of the Duke Blue Devils mascot. Text reads 'Why I’m Riding Daniel Nussbaum, MD.'
Join the @DukeMets for its annual research retreat, featuring sessions and panel discussions on ongoing research and innovations at Duke.
📆 Thursday, Oct. 1
⏰ 8 a.m.-2 p.m.
📍 Trent Semans Center for Health Education - Great Hall
duke.is/j/jaen@DukeMedSchool
A new study led by DCI researchers offers important insights into that challenge in advanced prostate cancer and could help pave the way for more personalized treatment approaches in the future.
duke.is/c/tbvz#ProstateCancer | @DukeMedSchool | @DukeHealth
Duke Health is expanding access to groundbreaking cell and gene therapies, bringing more options and hope to patients facing cancer and other serious diseases.
More: dukecancerinstitute.org/blog…@DukeCancer
Join us at Duke Rides for an indoor cycling relay benefiting DCI. Grab your team (4+ riders) and register today: duke.is/DukeRides
Together we ride. Together we fight.
📆 Saturday, Oct. 3
⏰ 12-5 p.m.
📍 Wilson Recreation Center, Durham, NC
Doctors at @DukeCancer Institute see a brighter future for pancreatic cancer patients. From immunotherapy to KRAS clinical trials, research is reaching a turning point, one that means more long-term survivors ahead. 💜
Link: piped.video/3jXvtGI0TJg
DCI's Jung Wook Park, PhD, recently received a grant to investigate new molecular mechanisms that drive one of the most aggressive forms of prostate cancer and to identify potential therapeutic targets.
duke.is/r/s5vc@DukePathDept | @DukeMedSchool
Radioligand therapies are approved to treat advanced prostate cancer and neuroendocrine tumors. DCI's Diane Reidy-Lagunes, MD, talks to Hannah McManus, MD, about the promises these therapies hold for the future.
duke.is/v/fjtb@DukeHealth | @DukeGUCancer
Research led by DCI's Jennifer Plichta, MD, suggests that some patients with limited metastatic breast cancer may benefit from a more aggressive treatment approach than has traditionally been offered.
duke.is/c/wb4c#BreastCancer | @DukeMedSchool | @DukeHealth
After years of treatment for his pancreatic cancer, a recurrence that threatened to derail his recovery and a last-minute acceptance into a clinical trial at Duke Health, one patient is now considered to have no evidence of disease.
duke.is/n/x7cp@DukeHealth
Duke Rides is coming! Recruit four or more riders, fundraise together, & earn your spot on the bikes for an indoor cycling relay. Every dollar raised fuels lifesaving cancer research and care.
Register your team & start fundraising today: duke.is/DukeRides@DukeMedSchool